Molecular markers to predict response to gefitinib: EGFR, ErbB-2, or more?
Normanno
Nicola
N
Di Maio
Massimo
M
Perrone
Francesco
F
Campiglio
Manuela
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism; D015986:Confounding Factors, Epidemiologic; D066246:ErbB Receptors / Q000008:administration & dosage / Q000378:metabolism*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib